EMERYVILLE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in May 2018.
Oppenheimer 3rd Annual Emerging Growth Conference
May 15, 2018
InterContinental Barclay Hotel in New York City
Amyris BioDisrupt 2018
May 22, 2018
11:00 a.m. – 4:30 p.m. Eastern Time/8:00 a.m. – 1:30 p.m. Pacific Time
B. Riley FBR 19th Annual Institutional Investor Conference
May 23, 2018
10:30 a.m. Eastern Time/7:30 a.m. Pacific Time
Loews Santa Monica Beach Hotel in Santa Monica, CA
Due to the one-on-one meeting format of the Oppenheimer conference no webcast will be available. A live videocast, as well as a replay of a portion of the Amyris BioDisrupt 2018 event with slides will be available on the investor relations section of the company’s website at http://investors.amyris.com. A live audio only webcast, as well as a replay of the B. Riley FBR presentation with slides will also be available on the investor relations section of the website. During the Amyris BioDisrupt 2018 and B. Riley FBR events Amyris will provide an update on its business.
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise™ products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris, the Amyris logo and No Compromise are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
Director, Investor Relations and Corporate Communications
+1 (510) 740-7481
Source: Amyris, Inc.